SCHEMBL4036713

SCHEMBL4036713

Cc1cccc(C)c1Nc1nc2ccc(N(CCO)CCO)nc2n2cncc12

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.55
SRC P12931 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044783 0.93 LCK (0.61) LCKSRC
SCHEMBL4039642 0.91 LCK (0.54) LCKSRC
SCHEMBL4039029 0.85 LCK (0.59) LCKSRC
SCHEMBL4040544 0.85 LCK (0.50) LCKSRC
SCHEMBL4044146 0.83 LCK (0.70) LCKSRC
SCHEMBL8400907 0.83 LCK (0.52) LCKSRC
SCHEMBL4036241 0.82 LCK (0.51) LCKSRC
SCHEMBL4036352 0.82 LCK (0.51) LCKSRC
SCHEMBL4038784 0.82 LCK (0.51) LCKSRC
SCHEMBL4045069 0.81 LCK (0.52) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP claimed
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed